The Leeds Multidisciplinary Research Tissue Bank (RTB) was given favourable ethical opinion by the Leeds (East) Research Ethics Committee on 3rd March 2010 (Ethics ref: 10/H1306/7). The RTB has evolved from activities undertaken within the Clinical Biomedical Proteomics Group in the CR-UK Centre in Leeds. These activities largely focussed on collection of samples relating to kidney disease, kidney transplant and acute kidney injury. The RTB has recently broadened to support wider activities within the Leeds CR-UK Centre and now collects and stores clinical samples from a number of other disease areas including colorectal cancer, neuro-oncology, ovarian cancer and bladder cancer. An overview of our sample collection can be found here.
The Joint Research Tissue Bank (RTB) Management committee has been established to manage and develop the Leeds Multidisciplinary and Leeds NIHR Biomarker Research Tissue Banks in terms of best practice. The committee will ensure that:
- Samples are used for maximum benefit in medical research
- The use of the samples is ethical and in accordance with the wishes of the donors and that at all times the dignity and rights of the individuals are respected
- The RTB is compliant with the Human Tissue Act 2004 and other relevant policies
- Policies and practices of the RTBs develop in line with and in response to any new regulations or guidance
- Quality and safety standards are maintained both technically in tissue acquisition, storage and associated relevant data maintenance and in appropriate use of the samples, and administratively in terms of communication with patients/volunteers, obtaining of consent and maintenance of records
- Policies and criteria are developed and in place to ensure that new initiatives applying to contribute to the RTB can achieve the desired standards as above and that they are being undertaken with appropriate clinical and scientific needs in mind and infrastructure in place